LD2A.3ICD-11 MMS 2026-01
46,XY disorder of sex development due to a defect in testosterone metabolism
Index terms
- 46,XY disorder of sex development due to a defect in testosterone metabolism
- 46,XY DSD due to a defect in testosterone metabolism
- 46,XY disorder of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency
Show allHide
- 17-beta-hydroxysteroid dehydrogenase 3 deficiency
- 17-ketoreductase deficiency
- 17-ketosteroidreductase deficiency
- 46,XY DSD due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency
- Male pseudohermaphroditism due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency
- 46,XY disorder of sex development due to 5-alpha-reductase 2 deficiency
- 46,XY DSD due to 5-alpha-reductase 2 deficiency
- Male pseudohermaphroditism due to 5-alpha-reductase 2 deficiency
- 46,XY disorder of sex development due to isolated 17, 20 lyase deficiency
- 46,XY DSD due to isolated 17, 20 lyase deficiency
- Leydig cell hypoplasia
- 46,XY DSD due to LH defects
- 46,XY disorder of sex development due to LH defects
- LH resistance due to LH receptor inactivation
- Male pseudohermaphrodism due to LH defects
- LH resistance due to complete LH receptor inactivation
- LH resistance due to partial LH receptor inactivation
Excludes
5A71.01– Congenital adrenal hyperplasia
Exclusions from above levels
5A71– pseudohermaphroditism: female, with adrenocortical disorder- http://id.who.int/icd/entity/733825440 – Inborn errors of metabolism
Sibling codes
LD2A.0– Ovotesticular disorder of sex developmentLD2A.1– 46,XY gonadal dysgenesisLD2A.2– Testicular agenesisLD2A.4– 46,XY disorder of sex development due to androgen resistanceLD2A.Y– Other specified malformative disorders of sex developmentLD2A.Z– Malformative disorders of sex development, unspecified
Foundation entity
46,XY disorder of sex development due to a defect in testosterone metabolism – http://id.who.int/icd/entity/749282256
Part of: LD2A: Malformative disorders of sex development › 20: Developmental anomalies